Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

New alpha-glucosidase inhibitors from a natural source

A kind of technology of glucosidase, inhibitor, applied in the field of new natural source glucosidase inhibitor

Inactive Publication Date: 2005-12-14
COUNCIL OF SCI & IND RES
View PDF0 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although several drugs targeted for use as α-glucosidase inhibitors are either still under clinical investigation or at various stages of clinical development (Drugs of the future 1986, 11, 795-797; Dugs of the future 1986, 11, 1039 -1042; Watson A.A et al., Phytochemistry 2001, 56, 265-295), their effect on the diseases discussed above still does not make it a definitive new agent

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • New alpha-glucosidase inhibitors from a natural source
  • New alpha-glucosidase inhibitors from a natural source
  • New alpha-glucosidase inhibitors from a natural source

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0035] According to the purpose of the present invention, the present invention provides the method for inhibiting the α-glucosidase of individual, described method is to the individual administration effective dose pharmaceutical composition, and described composition comprises and is selected from pipataline (formula 1a), sesamin Alpha-glucosidase inhibitors of (formula 1b), parittomide (formula 1c), guineensine (formula 1d) and brachystamide-B (formula 1e) and pharmaceutically acceptable ingredients, the pharmaceutical composition can be used for the treatment of individual Suffering from diseases such as hyperglycemia, hyperinsulinemia, hyperlipoproteinemia, cancer, viral infection, hepatitis B and C, HIV and AIDS.

[0036] In one embodiment of the invention, pipataline provides α-glucosidase inhibitory activity up to 77.45%, IC 50 The value was 26.52 (μg / ml).

[0037] In yet another embodiment of the present invention, sesamin provides α-glucosidase inhibitory activity u...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a method for providing alpha -glucosidase inhibition to a subject by administering a pharmaceutical composition comprising a alpha -glucosidase inhibitory agent selected from pipataline (formula 1a), sesamin (formula 1b), pellitorine (Formula 1c), guineensine (Formula 1d) and brachystamide-B (formula 1e) having therapeutic application for diabetes mellitus, cancer, viral diseases such as hepatitis B and C, HIV, AIDS etc; also the invention provides a process for the isolation of said alpha -glucosidase inhibitory agent from the plant source Piper longum in significant yields.

Description

technical field [0001] The present invention relates to the method that the glucosidase of body is inhibited by administering a kind of pharmaceutical composition, and described composition comprises and is selected from , an alpha-glucosidase inhibitor of guineensine (formula 1d) and brachystamide-B (formula 1e). In particular, the present invention relates to the isolation of the above five compounds, namely, pipataline [5-(1-dodecenyl)-1,3-benzodioxolane], sesame Element [5,5-(tetrahydro-1H,3H-furo(3,4-e)furan-1,4 diyl)bis-1,3-benzodioxolane], pyritolide [ N-(2-methylpropyl)-2,4-decadienamide], guineensine[13-(1,3-benzodioxolan-5-yl)-N(2-methylpropane base)-2,4,12-tridecenylamide] and brachystamide-B[15-(1,3-benzodioxolan-5-yl)-N(2-methylpropyl)- 2,4,14-Pentadecenetrienamide]. The present invention also finds that such compounds are used as α-glucosidase inhibitors, and used in the form of suitable pharmaceutical compositions for treating diabetes, cancer, and viral dis...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/164A61K31/36A61K36/67A61P3/06A61P3/10
CPCA61K31/164A61K31/36A61K36/67A61P3/06A61P3/10
Inventor 贾纳斯维梅·马杜苏德纳·拉奥普莱拉·文卡塔·斯里尼瓦斯武门萨拉·阿努拉德哈阿肖克·库马尔·蒂瓦里阿姆图·泽赫拉·阿里杰赫鲁·辛格·亚达夫孔达普拉·维贾雅·拉加万
Owner COUNCIL OF SCI & IND RES
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com